Skip to content

poudre et solvant pour solution injectable

DRUG10 trials

Sponsors

Institut Gustave Roussy, Assistance Publique Hopitaux De Paris, University Hospital Of Clermont-Ferrand, Centre Hospitalier Regional Universitaire, Unicancer

Conditions

Acute Anterior Ischemic Optic Neuropathy associated with Giant Cell Arteritis in Horton's DiseaseColorectal cancerHematological malignancyIntermediate risk prostate cancerProstatic adenocarnicoma with high risk of recurrenceThyroid Diseases Hypoparathyroidism Hypocalcemiaepidermoid carcinomaparaneoplastic sensory neuropathy with anti-Hu antibodies

Phase 2

Etude évaluant l’imagerie proche infrarouge couplée au vert d’indocyanine pour le contrôle peropératoire des marges de résection en chirurgie ORL (MAGNOLIA)
RecruitingCTIS2022-502737-26-00
Institut Gustave Roussyepidermoid carcinoma
Start: 2020-12-15Target: 65Updated: 2025-05-06
Early immunotherapy with intravenous immunoglobulin, cyclophosphamide and methylprednisolone in patients with anti-Hu-associated paraneoplastic sensory neuropathy (NESPA).
RecruitingCTIS2023-506942-22-01
Assistance Publique Hopitaux De Parisparaneoplastic sensory neuropathy with anti-Hu antibodies
Start: 2025-01-10Target: 21Updated: 2025-04-23
FORMAT Study : Use of fibrinogen in the treatment of bleeding in thrombopenic patients after intensive chemotherapy refractory to platelet transfusion - evaluation by rotem viscoelastometry (pilot single-center study).
CompletedCTIS2024-516494-73-00
Centre Hospitalier Universitaire De Saint EtienneHematological malignancy
Start: 2022-02-10End: 2025-12-17Target: 10Updated: 2024-10-24
EvaluatioN of High-Intensity Focused Ultrasound (HIFU) Hemi-ablation and short-term AndrogeN deprivation therapy Combination to Enhance prostate control for intermediate risk localized prostate cancer: the ENHANCE prospective feasibility trial
RecruitingCTIS2024-518680-36-00
Institut Mutualiste Montsouris, Institut Mutualiste MontsourisIntermediate risk prostate cancer
Start: 2023-03-07Target: 20Updated: 2024-10-25
French prospective open label phase II randomized non-comparative study of SC tocilizumab associated with IV pulse steroid versus IV pulse steroid alone for the treatment of acute anterior ischemic optic neuropathy associated with giant cell arteritis. (TOCIAION)
Not yet recruitingCTIS2024-519977-20-00
Centre Hospitalier National D'Ophtalmologie Quinze-VingtsAcute Anterior Ischemic Optic Neuropathy associated with Giant Cell Arteritis in Horton's Disease
Target: 58Updated: 2025-01-27

Phase 3

Phase 4